Dr. Michael L. Dougan

Claim this profile

Massachusetts General Hospital

Studies Melanoma
Studies Skin Cancer
2 reported clinical trials
3 drugs studied

Area of expertise

1Melanoma
Michael L. Dougan has run 1 trial for Melanoma. Some of their research focus areas include:
Stage III
Stage IV
2Skin Cancer
Michael L. Dougan has run 1 trial for Skin Cancer. Some of their research focus areas include:
Stage III
Stage IV

Affiliated Hospitals

Image of trial facility.
Massachusetts General Hospital

Clinical Trials Michael L. Dougan is currently running

Image of trial facility.

Infliximab

for Colitis in Melanoma

The goal of this clinical trial is to compare the safety and effectiveness of infliximab compared to steroids for the treatment of immune checkpoint inhibitor-induced colitis (ICI colitis) in patients with stage III/IV skin cancer. The main questions this study aims to answer are: * How many patients treated with infliximab experience steroid-free disease resolution after 7 weeks? * How many patients treated with steroids experience steroid-free disease resolution after 7 weeks?
Recruiting3 awards Phase 2

More about Michael L. Dougan

Clinical Trial Related4 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Michael L. Dougan has experience with
  • Infliximab
  • Placebo
  • Tirzepatide
Breakdown of trials Michael L. Dougan has run
Melanoma
Skin Cancer
Colitis
Adverse Drug Reaction
Antibiotic-associated colitis

Other Doctors you might be interested in

Suman Srinivasa, MDMassachusetts General Hospital
Daniel C. Chung, MDMassachusetts General Hospital
Gregory Cote, MDDana-Farber - Harvard Cancer Center LAO

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael L. Dougan specialize in?
Michael L. Dougan focuses on Melanoma and Skin Cancer. In particular, much of their work with Melanoma has involved Stage III patients, or patients who are Stage IV.
Is Michael L. Dougan currently recruiting for clinical trials?
Yes, Michael L. Dougan is currently recruiting for 1 clinical trial in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Michael L. Dougan has studied deeply?
Yes, Michael L. Dougan has studied treatments such as Infliximab, Placebo, Tirzepatide.
What is the best way to schedule an appointment with Michael L. Dougan?
Apply for one of the trials that Michael L. Dougan is conducting.
What is the office address of Michael L. Dougan?
The office of Michael L. Dougan is located at: Massachusetts General Hospital, Boston, Massachusetts 02114 United States. This is the address for their practice at the Massachusetts General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top